In 2023, China led global insulin imports, holding a substantial market share, followed by France and Italy. Notably, significant year-on-year growth was observed in the Philippines, Slovakia, Malaysia, Denmark, and Switzerland. However, the United States and Poland experienced declines. Emerging markets like Singapore, Argentina, and Morocco demonstrated positive growth trends, indicating their increasing role in the market. Conversely, traditional markets such as Germany and the United Kingdom saw reductions in their import shares.
Future trends to watch for in global insulin imports include:
- Continuous rise in Asian markets, particularly the Philippines and Malaysia, driven by increasing diabetic populations.
- Stable growth in mature markets such as China and France.
- Potential recovery in the United States and Germany due to advancements in healthcare infrastructure and regulations.
- Emerging markets like Qatar and Angola indicating significant growth, reflecting expanding access to healthcare.
Top countries in Import of Insulin Share by Country (US Dollars)
# | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
---|---|---|---|---|---|---|
1 | 1 China | 32.58 | 2023 | +5.31% | +5.09% | View data |
2 | 2 France | 27.04 | 2023 | +1.15% | +1.6% | View data |
3 | 3 Italy | 21.93 | 2023 | +4.91% | +5.07% | View data |
4 | 4 Russia | 4.03 | 2023 | +3.82% | +0.61% | View data |
5 | 5 United States | 2.76 | 2023 | -5.78% | -5.56% | View data |
6 | 6 India | 1.11 | 2023 | -0.62% | -0.56% | View data |
7 | 7 Egypt | 0.88 | 2023 | +4.69% | +0.79% | View data |
8 | 8 Ukraine | 0.26 | 2023 | -0.53% | -2.87% | View data |
9 | 9 Singapore | 0.22 | 2023 | +4.37% | +10.75% | View data |
10 | 10 Belarus | 0.2 | 2023 | +3.19% | +3.76% | View data |